Alley Co LLC decreased its position in shares of CME Group Inc. (NASDAQ:CME) by 8.5% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 30,535 shares of the financial services provider’s stock after selling 2,830 shares during the quarter. CME Group accounts for 1.5% of Alley Co LLC’s portfolio, making the stock its 29th largest position. Alley Co LLC’s holdings in CME Group were worth $4,143,000 at the end of the most recent quarter.
Several other large investors have also recently bought and sold shares of the company. BlackRock Inc. boosted its holdings in CME Group by 2,172.6% in the first quarter. BlackRock Inc. now owns 27,265,611 shares of the financial services provider’s stock worth $3,239,152,000 after purchasing an additional 26,065,883 shares during the last quarter. Janus Henderson Group PLC boosted its holdings in CME Group by 13,530.7% in the second quarter. Janus Henderson Group PLC now owns 6,150,016 shares of the financial services provider’s stock worth $770,227,000 after purchasing an additional 6,104,897 shares during the last quarter. Fiera Capital Corp raised its position in CME Group by 243.9% in the second quarter. Fiera Capital Corp now owns 1,926,918 shares of the financial services provider’s stock worth $241,327,000 after acquiring an additional 1,366,557 shares during the period. Wells Fargo & Company MN raised its position in CME Group by 25.5% in the second quarter. Wells Fargo & Company MN now owns 4,379,568 shares of the financial services provider’s stock worth $548,496,000 after acquiring an additional 889,217 shares during the period. Finally, BT Investment Management Ltd bought a new position in CME Group in the second quarter worth approximately $95,104,000. Hedge funds and other institutional investors own 82.63% of the company’s stock.
In other CME Group news, CFO John W. Pietrowicz sold 5,175 shares of the business’s stock in a transaction dated Thursday, November 2nd. The shares were sold at an average price of $139.70, for a total value of $722,947.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO John W. Pietrowicz sold 2,500 shares of the business’s stock in a transaction dated Wednesday, October 11th. The shares were sold at an average price of $136.83, for a total transaction of $342,075.00. The disclosure for this sale can be found here. Insiders sold a total of 11,339 shares of company stock valued at $1,548,086 over the last three months. Corporate insiders own 0.57% of the company’s stock.
Several research analysts have weighed in on CME shares. Barclays PLC started coverage on shares of CME Group in a research report on Friday, September 8th. They issued an “overweight” rating and a $139.00 price target on the stock. BidaskClub downgraded shares of CME Group from a “buy” rating to a “hold” rating in a research report on Friday, September 1st. UBS AG reiterated a “buy” rating and issued a $135.00 price target (up from $134.00) on shares of CME Group in a research report on Wednesday, September 6th. Citigroup Inc. increased their price target on shares of CME Group from $138.00 to $155.00 and gave the stock a “buy” rating in a research report on Thursday, October 19th. Finally, Wells Fargo & Company raised their price objective on shares of CME Group from $130.00 to $145.00 and gave the company a “market perform” rating in a research report on Wednesday, October 4th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and seven have given a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus price target of $141.75.
CME Group Inc. (CME) opened at $140.20 on Wednesday. CME Group Inc. has a 52 week low of $111.19 and a 52 week high of $141.07. The company has a market cap of $47,450.00, a price-to-earnings ratio of 28.84, a price-to-earnings-growth ratio of 2.82 and a beta of 0.71. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 0.11.
CME Group (NASDAQ:CME) last issued its quarterly earnings data on Thursday, October 26th. The financial services provider reported $1.19 EPS for the quarter, topping analysts’ consensus estimates of $1.16 by $0.03. CME Group had a net margin of 40.94% and a return on equity of 7.89%. The business had revenue of $890.80 million during the quarter, compared to analysts’ expectations of $890.22 million. During the same period last year, the company posted $1.05 EPS. The business’s revenue was up 5.8% on a year-over-year basis. sell-side analysts anticipate that CME Group Inc. will post 4.8 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 27th. Shareholders of record on Friday, December 8th will be paid a $0.66 dividend. The ex-dividend date is Thursday, December 7th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 1.88%. CME Group’s payout ratio is currently 59.86%.
About CME Group
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.